Paragonix SherpaPak Cardiac Transport System
News | Cardiovascular Surgery
Paragonix Technologies SherpaPak Improves 1-Year Survival in Heart Transplant Patients in Real-World Study

April 29, 2022 – Paragonix Technologies, Inc., a leading organ preservation provider, announces today groundbreaking ...

Home April 29, 2022
Home
Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring (i.e., Holter monitors and 30-day external monitors) may not be optimally managed for recurrent stroke prevention versus those who received continuous monitoring with insertable cardiac monitors.
News | Implantable Cardiac Monitor (ICM)
New Simulation Data From the STROKE AF Study Shows Insertable Cardiac Monitors Detect 4 Times More AF than Intermittent Monitoring
April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small ...
Home April 29, 2022
Home
Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap.
News | EP Mapping and Imaging Systems
Vektor Medical to Present Positive Results from vMap Clinical Validation Study
April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” ...
Home April 29, 2022
Home
Aurora St. Luke’s Medical Center in Milwaukee is the first site in the country to join a clinical trial studying machine-learning software designed to help novice users perform an echocardiography exam.
News | Cardiovascular Ultrasound
Study Evaluates AI Software that Aids Novice Users Performing Echocardiogram

April 29, 2022 – Aurora St. Luke’s Medical Center in Milwaukee is the first site in the country to join a clinical trial ...

Home April 29, 2022
Home
Medical center building
News | Cardiovascular Business
GE Healthcare and Medtronic Announce Collaboration to Meet Growing Need for Outpatient Care
April 29, 2022 – Providing excellent care inside and outside of the traditional hospital is the new normal for patients ...
Home April 29, 2022
Home
HIMSS22 showed that the industry is back on track, with leading organizations showcasing solutions for staff shortages and related burnout, cybersecurity, digital transformation, image convergence and efficiency
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Reimagining Health at HIMSS22

You could feel the energy and excitement at the 2022 HIMSS Global Health Conference & Exhibition (HIMSS22) held this ...

Home April 29, 2022
Home
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
News | Pharmaceuticals
FDA Approves Bristol Myers' Camzyos (mavacamten) Oral Heart Disease Drug

April 29, 2022 — Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos ...

Home April 29, 2022
Home
During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a technological research and consulting firm, presented the trends and top predictions in healthcare and life sciences for 2022.
Blog | Cardiovascular Business
The Digital Divide

During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a ...

Home April 29, 2022
Home
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that patients who have the Medtronic Heartware Ventricular Assist Device (HVAD) System and appear to present with pump thrombosis may have a welding defect in the internal pump causing the pump to malfunction.
News | Ventricular Assist Devices (VAD)
FDA Alert: Potential for Internal Pump Malfunction in the Medtronic HVAD System

April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...

Home April 28, 2022
Home
Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce major cardiovascular events, according to a new study published in the journal Radiology: Cardiothoracic Imaging.
News | CT Angiography (CTA)
Aspirin Does Not Cut Risk in Non-Obstructive Coronary Artery Disease

April 28, 2022 — Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce ...

Home April 28, 2022
Home
Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced new measures that will allow consumers to more easily find the right form of quality, affordable health care coverage on HealthCare.gov that best meets their needs.
News | Cardiovascular Business
HHS Announces New Policy to Make Coverage More Accessible and Affordable for Millions of Americans in 2023

April 28, 2022 — Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid ...

Home April 28, 2022
Home
This ERC Advanced Grant is awarded to scientists with more than ten years of research experience who have already played a prominent role in their field.
News | Heart Failure
MDC Receives ERC Advanced Grant for Cardiac Research
April 27, 2022 – The contractile and elastic properties of the heart are finely tuned. This is a prerequisite for the ...
Home April 27, 2022
Home
Omega Medical Imaging has announced the release of the revolutionary Soteria.AI.
News | Interventional Radiology
Omega Introduces Soteria.AI Interventional Cardiology System

April 27, 2022 – Omega Medical Imaging has announced the release of the revolutionary Soteria.AI. Designed specifically ...

Home April 27, 2022
Home
Medtronic Harmony FDA recall The FDA has identified this as a Class I recall, the most serious type of recall
News | Heart Valve Technology
Medtronic Recalls Harmony Delivery Catheter, Part of TPV System, for Risk of Capsule Break During Use

April 27, 2022 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall for the Medtronic Harmony ...

Home April 27, 2022
Home
CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, announced the completion of patient enrollment in the CathVision ECGenius System clinical evaluation study at the University of Vermont Medical Center.
News | EP Lab
CathVision Announces Completion of Patient Enrollment at First U.S. Clinical Trial Evaluating High-Fidelity, Low-Noise EP Recording Technology

April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home April 27, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now